Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

167150

registered interest
date	01/12/2014
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Driving: Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what recent discussions he has had with the Driver and Vehicle Licensing Agency on its medical standards for people with type-2 diabetes; and if he will make a statement.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216628
answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>The Secretary of State appointed the Honorary Medical Advisory Panel on Driving and Diabetes Mellitus to provide expert advice on the medical standards required for safe driving in relation to diabetes. The Panel meets twice a year and provides advice to the Driver and Vehicle Licensing Agency. The Panel last met in October 2014.</p> answering member constituency Devizes answering member printed Claire Perry question first answered 04/12/2014 14:29:40 answering member 3974 label Biography information for Claire Perry
tabling member	1538 label Biography information for Rosie Cooper

167151

registered interest
date	01/12/2014
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Driving: Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what steps his Department is taking to ensure that drivers with type-2 diabetes do not lose their licence as a result of hypoglycaemia.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216629
answer	answer is ministerial correction date of answer 04/12/2014 answer text <p>The Department for Transport is responsible for maintaining road safety for all road users. Those who are not medically fit to drive should not be issued with a driving licence.</p><p> </p><p>The Driver and Vehicle Licensing Agency (DVLA) provides information to drivers with diabetes, including the symptoms of hypoglycaemia. The DVLA has also worked with organisations representing people with diabetes to provide clear information about the standards required for driving.</p> answering member constituency Devizes answering member printed Claire Perry question first answered 04/12/2014 14:30:44 answering member 3974 label Biography information for Claire Perry
tabling member	1538 label Biography information for Rosie Cooper

166758

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with NHS England on the need to recognise levels of unmet need in pancreatic cancer when re-evaluating treatments on the Cancer Drugs Fund.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216451
answer	answer is ministerial correction date of answer 05/12/2014 answer text <p>We have had no such discussions. These are matters for NHS England’s Cancer Drugs Fund clinical panel.</p><p> </p><p> </p><p> </p><p>The panel plans to meet on 15 and 16 December to assess, on the basis of the latest evidence, whether certain drugs should continue to be made routinely available to new patients through the Fund and to consider a number of new drugs for potential addition to the Fund.</p><p> </p><p> </p><p> </p><p>In making such decisions, the panel will take into account a number of factors, including unmet need.</p><p> </p><p> </p><p> </p><p>NHS England has assured the Department that no patient whose treatment is currently being funded through the Fund will have funding withdrawn, as long as it is clinically appropriate that they continue to receive that treatment. In addition, no drug will be removed from the Fund where it is the only therapy for that condition.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 05/12/2014 14:19:34 answering member 4020 label Biography information for George Freeman
tabling member	1538 label Biography information for Rosie Cooper

166765

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hazardous Substances: Waste Disposal
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken to ensure that sufficient assessment of modern hazardous waste sites has been undertaken by the Health Protection Agency to enable understanding of the potential public health risks associated with such sites.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216467
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>The former Health Protection Agency (HPA) became part of Public Health England (PHE) in April 2013.</p><p> </p><p> </p><p> </p><p>In 2011, the HPA published a review of the ‘Impact on Health of Emissions from Landfill Sites’. This review included landfills for hazardous waste. The review considered research from the Environment Agency, peer reviewed epidemiological studies and statements from the independent expert committee, the Committee on Toxicity of Chemicals in Food, Consumer products and the Environment.</p><p> </p><p> </p><p> </p><p>The review concluded that there has been no new evidence to change the previous advice that living close to a well-managed modern landfill site does not pose a significant risk to human health. As noted in the review, detailed site-specific risk assessment should remain an important part of the permitting and management process. PHE is consulted by the Environment Agency when they receive permit applications and variations for landfill sites, to ensure that public health is protected.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/12/2014 17:05:23 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

166766

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he plans to take to ensure that all treatments for advanced pancreatic cancer shown to be effective are made available to patients on the NHS.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216468
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>The Government is committed to ensuring that patients have access to effective treatments, including those for pancreatic cancer, on terms that represent value to the National Health Service and the taxpayer.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies.</p><p> </p><p> </p><p> </p><p>NICE has recommended gemcitabine as a treatment option for pancreatic cancer in technology appraisal guidance published in May 2001, subject to certain clinical criteria, and has been asked to appraise a number of other pancreatic cancer drugs. NHS commissioners are legally required to fund treatments recommended by NICE technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>Surgery, radiotherapy and chemotherapy treatments that may be used for pancreatic cancer are commissioned by NHS England. NHS England’s pancreatic cancer service specification clearly defines what it expects to be in place for providers to offer evidence-based, safe and effective pancreatic cancer services.</p><p> </p><p> </p><p> </p><p>NHS England has also committed to make up to £6 million available over the next three years to support six trials by Cancer Research UK - one of which will be on pancreatic cancer - into the use of Stereotactic Ablative Radiotherapy (SABR), an innovative radiotherapy treatment. This will allow patients to receive SABR treatment where clinicians think they could benefit. At the same time doctors can fully assess the effectiveness of this treatment so that, if it proves to be effective, it will be available for patients on the NHS where appropriate.</p><p> </p><p><strong> </strong></p><p> </p><p>We are commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 03/12/2014 17:17:38 answering member 4020 label Biography information for George Freeman
tabling member	1538 label Biography information for Rosie Cooper

166767

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pressure Sores
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate his Department has made of the proportion of pressure ulcers that are caused by poor continence care.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216469
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>Information concerning the cost of treating pressure ulcers is not separately identifiable within the reference costs that National Health Service trusts and NHS foundation trusts submit annually to the Department.</p><p> </p><p> </p><p> </p><p>NHS England has advised that no assessment has been made of the proportion of pressure ulcers that are caused by poor continence care. However, maintaining skin integrity and maintaining continence are both aspects of fundamental care.</p><p> </p><p> </p><p> </p><p>The NHS Safety Thermometer is the measurement tool for a programme of work to support patient safety improvement. It is used to record patient harms at the frontline, and to provide immediate information and analyses for frontline teams to monitor their performance in delivering harm free care.</p><p> </p><p>The NHS Safety Thermometer records the presence or absence of four harms:</p><p> </p><p>- pressure ulcers;</p><p> </p><p>- falls;</p><p> </p><p>- urinary tract infections in patients with a catheter; and</p><p> </p><p>- new venous thromboembolisms.</p><p> </p><p>These four harms were selected as the focus by the Department’s QIPP Safe Care programme because they are common, and because there is a clinical consensus that they are largely preventable through appropriate patient care. The concept of Harm Free Care was designed to bring focus to the patient’s overall experience. Patients are assessed in their care settings. Measurement at the frontline is intended to focus attention on patient harms and their elimination.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 216470 question first answered 03/12/2014 17:43:06 answering member 1439 label Biography information for Norman Lamb
tabling member	1538 label Biography information for Rosie Cooper

166768

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pressure Sores
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the NHS has spent on treating pressure ulcers in each of the last five years.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216470
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>Information concerning the cost of treating pressure ulcers is not separately identifiable within the reference costs that National Health Service trusts and NHS foundation trusts submit annually to the Department.</p><p> </p><p> </p><p> </p><p>NHS England has advised that no assessment has been made of the proportion of pressure ulcers that are caused by poor continence care. However, maintaining skin integrity and maintaining continence are both aspects of fundamental care.</p><p> </p><p> </p><p> </p><p>The NHS Safety Thermometer is the measurement tool for a programme of work to support patient safety improvement. It is used to record patient harms at the frontline, and to provide immediate information and analyses for frontline teams to monitor their performance in delivering harm free care.</p><p> </p><p>The NHS Safety Thermometer records the presence or absence of four harms:</p><p> </p><p>- pressure ulcers;</p><p> </p><p>- falls;</p><p> </p><p>- urinary tract infections in patients with a catheter; and</p><p> </p><p>- new venous thromboembolisms.</p><p> </p><p>These four harms were selected as the focus by the Department’s QIPP Safe Care programme because they are common, and because there is a clinical consensus that they are largely preventable through appropriate patient care. The concept of Harm Free Care was designed to bring focus to the patient’s overall experience. Patients are assessed in their care settings. Measurement at the frontline is intended to focus attention on patient harms and their elimination.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 216469 question first answered 03/12/2014 17:43:06 answering member 1439 label Biography information for Norman Lamb
tabling member	1538 label Biography information for Rosie Cooper

166561

registered interest
date	27/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dialysis Machines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential cost to the NHS of devolving the commissioning of dialysis from a single nationally-prescribed service to clinical commissioning groups; and what steps his Department plans to take to ensure that devolution of commissioning is achieved safely by April 2015.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216321
answer	answer is ministerial correction date of answer 02/12/2014 answer text <p>Assessments surrounding the transferring of renal dialysis from NHS England to clinical commissioning groups (CCGs) are ongoing. The Department of Health launched a public consultation on the recommendations put forward by the Prescribed Specialised Services Advisory Group (PSSAG) to transfer commissioning responsibility for renal services from NHS England to CCGs on 27 November 2014. PSSAG is a Department of Health appointed expert committee which was established in 2013 to provide the Secretary of State with advice and recommendations on specialised services</p><p> </p><p> </p><p> </p><p>This public consultation is specifically asking key stakeholders involved in the provision of renal dialysis what NHS England would need to do to ensure a safe transfer of commissioning responsibilities to CCGs. This consultation is also asking stakeholders specifically whether the current proposed timescales for the transfer of services are feasible.</p><p> </p><p> </p><p> </p><p>NHS England has advised that they are in dialogue with key stakeholders about both the opportunities and challenges of transferring responsibility for renal services. The head of the Specialised Services Task Force in NHS England recently met stakeholders from renal service representative groups and heard their concerns directly. A new Task and Finish group is being established by NHS England through the NHS Commissioning Assembly. This group will look specifically at what support CCGs would require to be able to safely and effectively commission services devolved to them.</p><p> </p><p> </p><p> </p><p>NHS England is committed to issuing commissioning guidance for the safe transfer of services from national NHS England responsibility to local CCG responsibility.</p><p> </p><p> </p><p> </p><p>The consultation closes on 9 January 2015.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/12/2014 15:22:31 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

166599

registered interest
date	27/11/2014
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Driving: Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what discussions his Department has had with the Driver and Vehicle Licensing Agency on the medical rules on driving with diabetes treated with sulphonylureas and glinides.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216320
answer	answer is ministerial correction date of answer 02/12/2014 answer text <p>The Secretary of State appointed the Honorary Medical Advisory Panel on Driving and Diabetes Mellitus to provide expert advice on the medical standards required for safe driving. The Panel meets twice a year and provides advice to the Driver and Vehicle Licensing Agency. Driving with diabetes treated with sulphonylureas and glinides was last discussed at the meeting held in October 2014. As a result the ‘At a Glance Guide to the Current Medical Standards of Fitness to Drive’ was updated to emphasise the need for appropriate glucose testing.</p> answering member constituency Devizes answering member printed Claire Perry question first answered 02/12/2014 16:52:50 answering member 3974 label Biography information for Claire Perry
tabling member	1538 label Biography information for Rosie Cooper

166284

registered interest
date	26/11/2014
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Members
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, for what reason there is a 15-day turnaround period for her private office to respond to urgent requests from hon. Members for a meeting with her.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216224
answer	answer is ministerial correction date of answer 01/12/2014 answer text <p>There is no fifteen day turnaround period when handling requests for meetings. Under normal circumstances, urgent requests from hon. Members for a meeting with the Secretary of State are dealt with in a timely manner.</p><p> </p><p>In this instance, the hon. Member’s office contacted the Department’s National Helpline but was not put through to the Secretary of State’s Private Office.</p><p>Officials have apologised to the hon. Member’s office for this, and for the delay that resulted, and officials have assured me that it will not happen again.</p> answering member constituency Bognor Regis and Littlehampton answering member printed Mr Nick Gibb question first answered 01/12/2014 16:46:03 answering member 111 label Biography information for Nick Gibb
tabling member	1538 label Biography information for Rosie Cooper